We are live on ! Find out more
CPV

Canaan Partners VIII Portfolio holdings

AUM $31M
1-Year Est. Return 45.38%
This Fund
S&P 500
This Quarter Est. Return
+21.17%
1 Year Est. Return
-45.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$50.2M
AUM Growth
-$6.11M
Cap. Flow
-$9.71M
Cap. Flow %
-19.34%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CDLX icon
Cardlytics
CDLX
+$9.71M

Sector Composition

Rank Sector Weight
1 Communication Services 58.62%
2 Healthcare 41.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDLX icon
1
Cardlytics
CDLX
$21.7M
$29.4M 58.62%
113,314
-48,500
-30% -$9.71M
LQDA icon
2
Liquidia Corp
LQDA
$7.48B
$20.8M 41.38%
2,597,681

Similar funds

Canaan Partners VIII's Q2 2019 Portfolio in Review

As of Q2 2019, Canaan Partners VIII held 2 positions worth $50.2M, down 11% from $56.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners VIII withdrew a net $9.71M in Q2 2019, reducing 1 holding. Its largest reduction was Cardlytics, cutting an estimated $9.71M.

By sector, the portfolio is most concentrated in Communication Services at 59% of assets, up from 48% a quarter earlier, followed by Healthcare.

  • Canaan Partners VIII's biggest Q2 2019 reduction was Cardlytics, cutting an estimated $9.71M.
  • Canaan Partners VIII's ten largest holdings make up 100% of its $50.2M portfolio in Q2 2019.
  • Canaan Partners VIII opened 0 new positions and closed 0 in Q2 2019.
  • Canaan Partners VIII's portfolio value fell 11% quarter-over-quarter to $50.2M.

Based on Canaan Partners VIII's 13F filing for Q2 2019, filed 17 Jul 2019.